Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bio-Rad Laboratories, Inc. (BIO.B : NYSE)
 
 • Company Description   
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $261.83 Daily Weekly Monthly
20 Day Moving Average: 105 shares
Shares Outstanding: 26.98 (millions)
Market Capitalization: $7,062.82 (millions)
Beta: 1.01
52 Week High: $321.12
52 Week Low: $225.29
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -16.28% -16.35%
12 Week -15.73% -16.57%
Year To Date -15.73% -16.17%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1000 ALFRED NOBEL DR
-
HERCULES,CA -
USA		 ph: 510-724-7000
fax: 1-510-7415815		 investor_relations@bio-rad.com http://www.bio-rad.com
 
 • General Corporate Information   
Officers
Norman Schwartz - Chief Executive Officer and Chairman
Norman Schwartz - President and Director
Roop K. Lakkaraju - Chief Financial Officer and Executive Vice Preside
Christine A. Tsingos - Vice President;Chief Financial Officer
Jeffrey L. Edwards - Director

Peer Information
Bio-Rad Laboratories, Inc. (CORR.)
Bio-Rad Laboratories, Inc. (RSPI)
Bio-Rad Laboratories, Inc. (CGXP)
Bio-Rad Laboratories, Inc. (BGEN)
Bio-Rad Laboratories, Inc. (GTBP)
Bio-Rad Laboratories, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 090572108
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 05/07/26
Share - Related Items
Shares Outstanding: 26.98
Most Recent Split Date: 3.00 (2.00:1)
Beta: 1.01
Market Capitalization: $7,062.82 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/07/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 26.39
PEG Ratio: -
Price Ratios
Price/Book: 0.95
Price/Cash Flow: 26.11
Price / Sales: 2.73
EPS Growth
vs. Year Ago Period: -13.45%
vs. Previous Quarter: 11.06%
Sales Growth
vs. Year Ago Period: 3.85%
vs. Previous Quarter: 6.16%
ROE
12/31/25 - 3.86
09/30/25 - 4.19
06/30/25 - 4.01
ROA
12/31/25 - 2.70
09/30/25 - 2.93
06/30/25 - 2.82
Current Ratio
12/31/25 - 5.62
09/30/25 - 5.44
06/30/25 - 5.12
Quick Ratio
12/31/25 - 4.19
09/30/25 - 3.94
06/30/25 - 3.67
Operating Margin
12/31/25 - 10.47
09/30/25 - 11.10
06/30/25 - 10.94
Net Margin
12/31/25 - 29.42
09/30/25 - -26.43
06/30/25 - 12.50
Pre-Tax Margin
12/31/25 - 38.54
09/30/25 - -32.95
06/30/25 - 17.62
Book Value
12/31/25 - 276.32
09/30/25 - 249.74
06/30/25 - 261.96
Inventory Turnover
12/31/25 - 1.60
09/30/25 - 1.56
06/30/25 - 1.53
Debt-to-Equity
12/31/25 - 0.16
09/30/25 - 0.18
06/30/25 - 0.17
Debt-to-Capital
12/31/25 - 13.88
09/30/25 - 15.13
06/30/25 - 14.42
 

Powered by Zacks Investment Research ©